Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by noodleyon Apr 23, 2011 8:01am
319 Views
Post# 18476850

RE: RE: RE: RE: RE: News but Not Really Newsworthy

RE: RE: RE: RE: RE: News but Not Really NewsworthySadly, mirc1...i'm with you on that one.  sct has had so many easy opportunties to move the sp over the past few months...but has chosen to do nothing.   the latest LEAP OF FAITH nr is eye-rolling stupid.  i'm thinking they're back using student interns (helps keep that burn rate down you see) to run the marketing like they did last may.  "announce our plans as soon as they are finalized"???   What plans?  When are ya gonna finalize?  And what ever happened to that unsolicited offer back in Novemeber?     naw...  time to look to get out of dodge. 
Bullboard Posts